Doctor profile · Federal record
Dr. ARUN AGARWAL, M.D.
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Internal Medicine Physician · Internal Medicine Physician · NEW BRITAIN, CT
- NPI 1326226044
- Accepts Medicare
- 21 yrs in practice
- Licensed in 2 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1 LAKE ST
NEW BRITAIN, CT 060521396
(860) 223-0220
Credentials & registration
- NPI registered
- February 2008 — 18 yrs on file
- Profile last updated
- January 21, 2013
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State licenses (2)
- Connecticut #050692 · New York #247371
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1326226044. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,205
Distinct HCPCS
10
Medicare allowed
$238,923
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 486 | 315 | $137 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 472 | 384 | $15 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 191 | 182 | $215 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 134 | 126 | $97 | |
J2785 |
Injection, regadenoson, 0.1 mg | 124 | 31 | $54 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 121 | 87 | $191 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 101 | 43 | $31 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 83 | 42 | $25 | |
A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose | 80 | 40 | $121 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 71 | 69 | $183 |
In context: peer comparison
Among 7 peers in this city , average services per provider: 112. This provider delivers 20× the peer median.Open Payments
Industry payments received
All-time total
$3,296
Transactions
111
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbott Laboratories | 10 | $477.84 | |
| Novartis Pharmaceuticals Corporation | 19 | $426.67 | |
| Novo Nordisk Inc | 13 | $349.92 | |
| PFIZER INC. | 13 | $343.18 | |
| Boston Scientific Corporation | 8 | $172.79 | |
| Janssen Pharmaceuticals, Inc | 8 | $172.62 | |
| Merck Sharp & Dohme LLC | 7 | $157.71 | |
| E.R. Squibb & Sons, L.L.C. | 8 | $143.75 | |
| Amgen Inc. | 6 | $142.86 | |
| Esperion Therapeutics, Inc. | 6 | $119.15 | |
| Inspire Medical Systems, Inc. | 1 | $106.95 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $77.68 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74.96 | |
| MEDICOMP INC | 2 | $70.76 | |
| ABIOMED | 2 | $70.12 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
6,214
Patients
1,859
Total drug cost
$1,731,178
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 1,107 | 276 | $1,417,959 |
| Rosuvastatin Calcium | Generic | 774 | 242 | $18,140 |
| Metoprolol Succinate | Generic | 639 | 204 | $14,688 |
| Atorvastatin Calcium | Generic | 571 | 179 | $8,548 |
| Metoprolol Tartrate | Generic | 435 | 136 | $5,316 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 402 | 127 | $7,150 |
| Amlodipine Besylate | Generic | 383 | 110 | $3,247 |
| Ezetimibe | Generic | 340 | 102 | $13,398 |
| Torsemide | Generic | 325 | 102 | $7,171 |
| Carvedilol | Generic | 288 | 85 | $3,716 |